Business

Bristol Myers Squibb Foundation Awards Grant to PATH to Improve Care for Inherited Blood Disorders in India

New initiative aims to build capacity in high-prevalence areas to increase screening and prevention of hemoglobinopathies NORTHAMPTON, MA / ACCESS Newswire / October 17, 2025 /PATH has launched a groundbreaking initiative to address the rising burden ...

articleBristol-myers Squibb CompanyOctober 17, 20252/company/bristol-myers-squibb-company/news/bristol-myers-squibb-foundation-awards-grant-to-path-to-improve-care-for-inherited-blood-disorders-in-india
Bristol Myers Squibb Foundation Awards Grant to PATH to Improve Care for Inherited Blood Disorders in India

About this update from Bristol-myers Squibb Company

[{"type":"text","content":"New initiative aims to build capacity in high-prevalence areas to increase screening and prevention of hemoglobinopathies","length":121,"tagName":"p"},{"type":"text","content":"NORTHAMPTON, MA / ACCESS Newswire / October 17, 2025 / PATH has launched a groundbreaking initiative to address the rising burden of hemoglobinopathies-particularly Thalassemia-in India, with the support of a grant from the Bristol Myers Squibb Foundation (BMS Foundation). The program aims to strengthen local health systems and expand access to early screening, diagnosis, and treatment in high-prevalence areas.","length":414,"tagName":"p"},{"type":"text","content":"India accounts for nearly 25% of the global β-thalassemia burden, with an estimated 10,000-15,000 children born each year with Thalassemia Major. Despite this, access to quality care remains limited, and treatment pathways are often fragmented.","length":244,"tagName":"p"},{"type":"text","content":"This initiative marks among the BMS Foundation's first grants in India to increase access to screening and build capacity to tackle the life-threatening burden of hemoglobinopathies.","length":186,"tagName":"p"},{"type":"text","content":"The program will be implemented in the states of Maharashtra and Madhya Pradesh, with a focus on:","length":97,"tagName":"p"},{"type":"text","content":"Strengthening screening and prevention: Focusing on high-prevalence districts and prioritizing key population groups such as pregnant women, newborns, and families with known genetic risk factors.","length":196,"tagName":"p"},{"type":"text","content":"Capacity-building and training: Equipping frontline health workers to deliver timely, evidence-based, and culturally sensitive care.","length":132,"tagName":"p"},{"type":"text","content":"Coordinated care systems: Ensuring linkage to management services, including safe blood transfusion services, iron chelation therapy, and bone marrow transplant facilities, where appropriate.","length":191,"tagName":"p"},{"type":"text","content":"Strengthening the Centre for Competence (CoC): Enhancing the ambit of existing CoCs for Sickle Cell Disease established by the Government of India under NSCAEM to serve as hubs of excellence for Thalassemia care.","length":212,"tagName":"p"},{"type":"text","content":"Policy integration and innovation: Supporting alignment of national and st...

More updates from Bristol-myers Squibb Company

BMS FoundationBristol Myers SquibbThalassemia MajorIndiaPATHIndiaFoundationACCESS Newswire